Seed Fonds II Aachen continues to invest in Hemovent
Aachen — Seed Fonds II Aachen makes a further financing investment in Hemovent GmbH. Together with the existing investors MIG-Investmentfonds, NRW.BANK, KfW Bankengruppe, First Capital Partner and the private investor Prof. Dr. Peter Borges, Aachener Beteiligungsgesellschaft is thus providing the necessary funds in the mid seven-digit range. With the fresh capital, the startup wants to realize, among other things, the market launch within the scope of a so-called “post-market study”. With this study, the Hemovent system “MOBYBOX” will be used on humans for the first time. In parallel, the founders are also seeking US FDA approval.
Hemovent GmbH has developed one of the world’s smallest portable ECMO systems (Extra Corporal Membrane Oxygenation, photo), which supports or even completely takes over the natural cardiopulmonary function in case of cardiopulmonary insufficiency or failure. Since the closing of the previous financing round in June 2017, the Aachen-based startup has successfully completed product development and the verification and validation phase. Extremely positive results have been achieved in the in vivo trials and the company expects CE certification later this year.
“Hemovent has been developing very positively since Seed Fonds II’s initial commitment,” says Markus Krückemeier, Managing Director of Seed Fonds Aachen II’s management company. “So far, the medtech company has been able to reach all milestones and even create additional value in some areas. We are very satisfied — both with the technological and the economic progress.”
“We have set our content milestones until mid-2020 and are working with a well-coordinated management team to be able to meet all targets on schedule,” says Christof Lenz, CEO and co-founder of Hemovent GmbH. “In order to firmly establish ourselves in the market, we have already been making contacts for years with clinical experts and users, institutionalized industry experts, and decision-makers from MedTech groups, and we are represented at trade congresses.”
About Seed Fonds II Aachen
Seed Fonds II Aachen was established in March 2012 as the successor to the fully financed first Seed Fonds Aachen (investment period: 2007–2011) as a follow-up fund from NRW.BANK’s Seed Fonds Initiative. In addition to NRW.BANK, Seed Fonds II Aachen is financed by Sparkasse Aachen and DSA Invest GmbH, which is backed by Aachen-based DSA Daten- und Systemtechnik GmbH. The Seed Fund provides young companies in the start-up phase with the necessary equity capital and thus stimulates the development of future-oriented technologies in the Aachen economic region. In 2018, the seed fund was launched for the third time and for the first time also includes the Mönchengladbach region, as the circle of investors has expanded to include Sparkasse Mönchengladbach.
Behind the operational management of the fund (FM Fonds-Management für die Region Aachen Beteiligungs-GmbH) are the investment experts of the S‑UBG Group. The investment company of the savings banks in the Aachen, Krefeld and Mönchengladbach area looks back on more than 30 years of experience in financing medium-sized companies and technology-oriented start-ups. www.seedfonds-aachen.de; www.s‑ubg.de.